A Phase 1/2 Trial of Cladribine, High-Dose Cytarabine, G-CSF, and Dose-Escalated Mitoxantrone (CLAG-M) Plus Gemtuzumab Ozogamicin in Adults with Newly-Diagnosed Acute Myeloid Leuke... by Godwin, Colin D., Othus, Megan, Percival, Mary-Elizabeth M., Hendrie, Paul C., Scott, Bart L., Appelbaum, Jacob S., Halpern, Anna B., Oehler, Vivian G., Orozco, Johnnie J., Keel, Sioban B., Abkowitz, Janis L., Cooper, Jason P., Cassaday, Ryan D., Orlowski, Kaysey F., Marshall, Anise J., Brown, Clarisa N., Estey, Elihu H., Walter, Roland B.

Get full text